Histone deacetylase

Dec 09, 2019

Advaite Inc. Enters into Exclusive License Option Agreement with the George Washington University for Novel AMES Negative HDAC6 Inhibitor Technology

Apr 26, 2019

Global HDAC (histone deacetylase) Inhibitors Market to 2023 Featuring Celgene, Merck & Co, Novartis, Shenzhen Chipscreen Biosciences, & Spectrum Pharmaceuticals

Mar 12, 2019

CStone received IND approval in China for HDAC6 inhibitor CS3003

Jun 18, 2018

Continued Discussions With FDA on Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study

May 18, 2018

Additional Remetinostat Phase II Data Will be Presented at the International Investigative Dermatology Meeting on May 18 and 19

May 02, 2018

OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug

Oct 13, 2017

Remetinostat Phase II Data Demonstrate Efficacy on Skin Lesions, Reduction of Itching and High Tolerability in Patients With Early-stage MF-type CTCL

Oct 12, 2017

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2017